Citeline Podcast: Trio Of Diagnostics Execs Weigh In On Upcoming Challenges

Immunexpress - the signature diagnostics for sepsis

From the Citeline podcast show notes: During this episode, Barnaby Pickering is joined by Rollie Carlson, CEO of Immunexpress, developer of Septicyte, a test for sepsis, Mark McDonough, CEO of ChromaCode, a company developing multiple blood-based tests for cancer diagnosis and treatment, with its first being in non-small cell lung cancer, and Lishan Aklog, CEO…

Read More

“Improving Outcomes For Patients With Sepsis” — Interview from Progress, Potential & Possibilities

Roland Carlson interview for Progress Potential Possibilities

“Today we have the honor of being joined by Dr Roland Carlson, who is the Chief Executive Officer of Immuneexpress which is a Seattle-based molecular diagnostic company they’re committed to improving the outcomes for patients suspected of having sepsis and their FDA-cleared SeptiCyte technology is focused on rapidly quantifying from whole blood specific molecular markers…

Read More

Rollie Carlson on How Cross-Training and Extreme Ownership Help You Advance Your Career

Carlson - Mastering Medical Device podcast

Immunexpress CEO Rollie Carlson recently appeared on the Mastering Medical Device podcast. Rollie Calrson is the CEO of Immunexpress, a company that is pioneering technology that can rapidly detect sepsis. Rollie contributed to the success of Abbott Laboratories for 20 years, starting off in R&D, then transitioning to leadership positions in global businesses and start-up…

Read More

“Immunexpress Nabs 510(k) Clearance for EDTA Blood-Compatible Cartridges”

Via 360Dx, ” Jan 04, 2024 | staff reporter NEW YORK – Immunexpress announced Thursday that it has secured US Food and Drug Administration 510(k) clearance for ethylenediaminetetraacetic acid (EDTA) blood-compatible cartridges for use with the firm’s SeptiCyte Rapid test to differentiate sepsis from infection-negative systemic inflammation. Read the rest here: 360Dx

Read More

In the News: Why Better Sepsis Diagnosis Results in Better Outcomes

Image from the CLP article

In Clinical Lab Products, Silvia Cermelli, PhD, and Prashant Wani, PhD say “The delay in sepsis diagnosis not only increases the risk of dying by as much as 8% every hour, but misdiagnosis leads to unnecessary use of strong antibiotic therapies causing health-related burdens on patients and economic burdens on healthcare systems.” Source: Clinical Lab…

Read More

PodcastDX: Richard Brandon on Sepsis Rapid Test

Richard Brandon on PodcastDX, Episode 19

This week we will discuss a new rapid response test for Sepsis with one of the developers, Richard Brandon.

Sepsis describes a syndrome that occurs when severe infection results in critical illness and affects 750,000 Americans annually. Sepsis occurs when a bacterial, viral, or fungal infection causes a significant response from the body’s immune system, causing a high heart rate, fever, or fast breathing. Severe sepsis develops when the infection causes organ damage. Septic shock is the most severe form in which the infection causes low blood pressure, resulting in damage to multiple organs. About three in every 10 patients with severe sepsis, and half of those with septic shock, die in the hospital.

Consider asking the following questions…

Read More

In the news: A Diagnostic Dilemma

IDTransmission

A sepsis thought leadership article from Richard Brandon PhD, CTO at Immunexpress has just been published in IDTransmission. Sepsis takes a heavy toll on society, causing millions of fatalities worldwide per year and costing upwards of US$50 billion yearly in the US alone. Sepsis can develop from viral, bacterial, and even fungal infections, but bacterial…

Read More